Stephen K. M.d. Klasko - 10 Sep 2025 Form 4 Insider Report for DocGo Inc. (DCGO)

Role
Director
Signature
/s/ Ely D. Tendler, as Attorney-in-Fact for Stephen K. Klasko, MD
Issuer symbol
DCGO
Transactions as of
10 Sep 2025
Net transactions value
$0
Form type
4
Filing time
11 Sep 2025, 17:20:13 UTC
Previous filing
14 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Klasko Stephen K. M.D. Director C/O DOCGO INC, 35 WEST 35TH STREET, FLOOR 6, NEW YORK /s/ Ely D. Tendler, as Attorney-in-Fact for Stephen K. Klasko, MD 11 Sep 2025 0001433241

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCGO Common Stock Award $0 +100,000 +667% $0.000000 115,000 10 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on September 10, 2026, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.